All primary glioblastoma cultures showed 91.2–99.3% expression of the cancer cell marker CD44, which is overexpressed in GBM [22], and 6.8–61.6% expression of GFAP, which is expressed by astrocytes and in astrocytic brain tumors [23]. This evidence concerns the gene CD44 and glioblastoma.